What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
ns. The report is made to the BASG or to the pharmaceutical company who is the marketing authorization holder or distributor of the medicinal product concerned. The BASG accepts the notifications online
registration office, have I received an error message when I submitted my annual registration via the BASG portal? What do I have to pay attention to when "Submitting a message"? Where can I get the necessary [...] carried out to check whether the technical requirements have been met. Please contact AGES (e-mail: basg-eservices@ages.at) if you have any questions regarding the procedure of the Vet-AB-MengenströmeVO [...] carried out to check whether the technical requirements have been met. Please contact AGES (e-mail: basg-eservices@ages.at) if you have any questions about the procedure of this procedure. AGES will send
templates for PDF with unlimited access (PDF/UA) The BASG has updated the accessible versions, which are available for download at https://www.basg.gv.at/en/companies/marketing-authorisation-life-cycl [...] information please refer to Accessible patient information leaflet - BASG , resp. FAQ Accessible patient information leaflet - BASG . CMDv - call for early submission and statistics Please find the call [...] SmPC, package leaflet and labelling . For further information please refer to FAQ online services - BASG . Based on the final package leaflet , an accessible PDF document has to be created and also uploaded
ance Union Product Database (UPD) Notification of pet products National Legislation / Information BASG talk NVR
the contact below. We will review your request and contact you as soon as possible. Contact: basg-eservices@basg.gv.at Enforcement proceedings In the event of unsatisfactory responses from the above contact [...] Accessibility statement Declaration on accessibility The Federal Office for Safety in Health Care (BASG) strives to make its website accessible in accordance with the Web Accessibility Act (WZG), as amended [...] Journal L 327, 2.12.2016, p. 1). This accessibility statement applies to the website nebenwirkung.basg.gv.at . Status of compatibility with the requirements This website is fully compliant with compliance
such as TV content, websites and Internet offerings. The Federal Office for Safety in Health Care (BASG) strives to make its website accessible in accordance with the Web Accessibility Act (WZG) as amended [...] your request and contact you as soon as possible. Please send all messages and suggestions to qmgt@basg.gv.at . Please describe the problem and provide us with the URL(s) of the respective page or document
What's new Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month ( link to subscription page ). For the RSS feed with daily notification of updates
Medicinal products Scientific advice by BASG Quality of medicines Medicines for children Plasma derived products Batch release Recombinant proteins Forms for medicinal products Controlled substances R
instructions for use are available at: https://www.basg.gv.at/fuer-unternehmen/online-service/nutzungshinweise Endpoint public Internet https://webservices.basg.gv.at/medicineshortage/export/v1/download Endpoint [...] healthcare professionals (yes/no) Rechtsgrundlage_Meldung Legal basis of the notification Hinweis_BASG Important BASG-information (optional) Information of the medicinal product per pack size Zulassungsnummer [...] Endpoint GIN https://webservices-ginet.basg.gv.at/medicineshortage/export/v1/download General information Since February 1, 2018, marketing authorisation holders and their authorised representatives have
a product on the market may submit an application to the Federal Office for Safety in Health Care (BASG) to determine whether this product falls within the definition of a medicinal product or a veterinary [...] documents. Within the scope of this procedure, pursuant to Section 1 (3b) AMG or Section 2 (5) TAMG, the BASG may obtain an expert opinion of the Delineation Commission pursuant to Section 49a AMG or Section [...] Alternatively, persons wishing to place a product on the market can submit an informal enquiry to BASG by e-mail , which is answered by e-mail without a formal expert opinion and without notification.